Developing an expert panel process to refine health outcome definitions in observational data

被引:8
作者
Fox, Brent I. [1 ]
Hollingsworth, Joshua C. [1 ]
Gray, Michael D. [2 ]
Hollingsworth, Michael L. [3 ]
Gao, Juan [1 ]
Hansen, Richard A. [1 ]
机构
[1] Auburn Univ, Harrison Sch Pharm, Dept Pharm Care Syst, Auburn, AL 36849 USA
[2] Hewlett Packard Labs, Palo Alto, CA 94304 USA
[3] Auburn Univ, Off Informat Technol, Auburn, AL 36849 USA
基金
美国国家卫生研究院;
关键词
Administrative claims; Expert panel; Observational; Dashboard; Health outcome of interest; ADVERSE DRUG-REACTIONS; BENEFIT CONSIDERATIONS; HOSPITAL ADMISSIONS; SAFETY SURVEILLANCE; COST; FREQUENCY;
D O I
10.1016/j.jbi.2013.05.006
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Objectives: Drug safety surveillance using observational data requires valid adverse event, or health outcome of interest (HOI) measurement. The objectives of this study were to develop a method to review HOI definitions in claims databases using (1) web-based digital tools to present de-identified patient data, (2) a systematic expert panel review process, and (3) a data collection process enabling analysis of concepts-of-interest that influence panelists' determination of HOI. Methods: De-identified patient data were presented via an interactive web-based dashboard to enable case review and determine if specific HOIs were present or absent. Criteria for determining HOIs and their severity were provided to each panelist. Using a modified Delphi method, six panelist pairs independently reviewed approximately 200 cases across each of three HOIs (acute liver injury, acute kidney injury, and acute myocardial infarction) such that panelist pairs independently reviewed the same cases. Panelists completed an assessment within the dashboard for each case that included their assessment of the presence or absence of the HOI, HOI severity (if present), and data contributing to their decision. Discrepancies within panelist pairs were resolved during a consensus process. Results: Dashboard development was iterative, focusing on data presentation and recording panelists' assessments. Panelists reported quickly learning how to use the dashboard. The assessment module was used consistently. The dashboard was reliable, enabling an efficient review process for panelists. Modifications were made to the dashboard and review process when necessary to facilitate case review. Our methods should be applied to other health outcomes of interest to further refine the dashboard and case review process. Conclusion: The expert review process was effective and was supported by the web-based dashboard. Our methods for case review and classification can be applied to future methods for case identification in observational data sources. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:795 / 804
页数:10
相关论文
共 28 条
  • [1] [Anonymous], OSCAR OBS SOURC CHAR
  • [2] [Anonymous], 2011, VAL HLTH OUTC
  • [3] [Anonymous], 2012, SENT IN NAT STRAT MO
  • [4] [Anonymous], 2011, ID HLTH OUTC
  • [5] [Baciu A. Institute of Medicine Institute of Medicine], 2007, The future of drug safety: Promoting and protecting the health of the public
  • [6] Developing the Sentinel System - A National Resource for Evidence Development
    Behrman, Rachel E.
    Benner, Joshua S.
    Brown, Jeffrey S.
    McClellan, Mark
    Woodcock, Janet
    Platt, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) : 498 - 499
  • [7] Evaluation of serious adverse drug reactions - A proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers
    Bennett, Charles L.
    Nebeker, Jonathan R.
    Yarnold, Paul R.
    Tigue, Cara C.
    Dorr, David A.
    McKoy, June M.
    Edwards, Beatrice J.
    Hurdle, John F.
    West, Dennis P.
    Lau, Denys T.
    Angelotta, Cara
    Weitzman, Sigmund A.
    Belknap, Steven M.
    Djulbegovic, Benjamin
    Tallman, Martin S.
    Kuzel, Timothy M.
    Benson, Al B.
    Evens, Andrew
    Trifilio, Steven M.
    Courtney, D. Mark
    Raisch, Dennis W.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (10) : 1041 - 1049
  • [8] Rapid Identification of Myocardial Infarction Risk Associated With Diabetes Medications Using Electronic Medical Records
    Brownstein, John S.
    Murphy, Shawn N.
    Goldfine, Allison B.
    Grant, Richard W.
    Sordo, Margarita
    Gainer, Vivian
    Colecchi, Judith A.
    Dubey, Anil
    Nathan, David M.
    Glaser, John P.
    Kohane, Isaac S.
    [J]. DIABETES CARE, 2010, 33 (03) : 526 - 531
  • [9] Ernst F R, 2001, J Am Pharm Assoc (Wash), V41, P192
  • [10] Adverse ocular drug reactions recently identified by the national registry of drug-induced ocular side effects
    Fraunfelder, FW
    Fraunfelder, FT
    [J]. OPHTHALMOLOGY, 2004, 111 (07) : 1275 - 1279